Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Paul Baker Insider Profile
4 Followers
Matthew Paul Baker, Director at Fusion Antibodies Plc, holds 237.57K shares in Fusion Antibodies Plc (Ticker: GB:FAB).
Matthew Paul Baker has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Matthew Paul Baker's holdings
Insider Roles
Director
Roles that Matthew Paul Baker holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Matthew Paul Baker
Matthew Paul Baker's Trading History
List of latest transactions for each holding click on a transaction to see Matthew Paul Baker's performance on stock
You May Also Like
Matthew Paul Baker insider profile FAQ
What is the percentage of profitable transactions made by Matthew Paul Baker?
The percentage of profitable transactions made by Matthew Paul Baker is ―.
What is the average return per transaction made by Matthew Paul Baker?
The average return per transaction made by Matthew Paul Baker is ―.
What stocks does Matthew Paul Baker hold?
Matthew Paul Baker holds: GB:FAB stocks.
What was Matthew Paul Baker’s latest transaction?
Matthew Paul Baker latest transaction was an Uninformative Buy of 3.37K.
What was Matthew Paul Baker's most profitable transaction?
Matthew Paul Baker’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Matthew Paul Baker's role in Fusion Antibodies Plc?
Matthew Paul Baker's role in Fusion Antibodies Plc is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.